Review
doi: 10.1111/j.1423-0410.1998.tb05459.x.
Analysis of CD34-expressing cells in clinical practice
Affiliations
- PMID: 9704484
- DOI: 10.1111/j.1423-0410.1998.tb05459.x
Item in Clipboard
Review
Analysis of CD34-expressing cells in clinical practice
Vox Sang.
1998.
Abstract
The flow cytometric determination of haemopoietic cells defined as CD34-expressing cells has greatly added to the improvement of the management of harvesting circulating haemopoietic cells for subsequent autologous reinfusion in the setting of high-dose chemo/(radio)-therapy. Additionally, this flow cytometric determination has replaced, in some institutions, the in-vitro culture test for CFU-GM as the measure to estimate the haemopoietic potential of the cells to be reinfused/transplanted.
Similar articles
-
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.Blood. 1991 Jan 15;77(2):400-9. Blood. 1991. PMID: 1702334
-
Multiparameter flow-cytometrical quantitation of circulating CD34(+)-cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assay.Br J Haematol. 1991 Apr;77(4):453-9. doi: 10.1111/j.1365-2141.1991.tb08609.x. Br J Haematol. 1991. PMID: 1709040
-
CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.Vox Sang. 1998;74 Suppl 2:477-82. doi: 10.1111/j.1423-0410.1998.tb05460.x. Vox Sang. 1998. PMID: 9704485
-
Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.Haematologica. 1991 Mar;76 Suppl 1:46-9. Haematologica. 1991. PMID: 1713874 Review.
-
The CD34 molecule and hematopoietic progenitor cell studies--a challenge in clinical medicine.Vox Sang. 1998;74 Suppl 2:467-8. doi: 10.1111/j.1423-0410.1998.tb05458.x. Vox Sang. 1998. PMID: 9704483 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
